Maxime Kurtz, Virginie Fabrès, Renaud Dumont, Valérie Chetboul, Sabine Chahory, Vittorio Saponaro, Emilie Trehiou, Camille Poissonnier, Peggy Passavin, Coline Jondeau, Matthieu Bott, Thierry Buronfosse, Ghita Benchekroun
BACKGROUND: In a previous study, telmisartan suppressed aldosterone secretion in healthy cats but not in cats with primary hyperaldosteronism (PHA). HYPOTHESES: Telmisartan suppresses aldosterone secretion in middle-aged healthy cat and cats with diseases that may result in secondary hyperaldosteronism, but not in those with PHA. ANIMALS: Thirty-eight cats: 5 with PHA; 16 with chronic kidney disease (CKD), subclassified as hypertensive (CKD-H) or non-hypertensive (CKD-NH); 9 with hyperthyroidism (HTH); 2 with idiopathic systemic arterial hypertension (ISH); and 6 healthy middle-aged cats...
2023: Journal of Veterinary Internal Medicine